Drugmaker Titan Ordered To Shut Down U.S. Operations

Law360, New York (February 8, 2013, 5:14 PM EST) -- California-based drug manufacturer Titan Medical Enterprises Inc. must shut down its U.S. operations after a federal judge ruled that the company failed to follow manufacturing regulations and illegally distributed unapproved new drugs, the U.S. Food and Drug Administration said Friday.

U.S. District Judge Otis D. Wright awarded summary judgment to the U.S. Department of Justice in a suit accusing Titan of failing to follow FDA standards for current good manufacturing practices, or cGMP. Titan repeatedly violated federal law by distributing tainted drugs and dietary supplements as...
To view the full article, register now.




Case Information

Case Title

United States of America v. Titan Medical Enterprises Inc et al

Case Number



California Central

Nature of Suit

Other Statutory Actions


Otis D. Wright, II

Date Filed

December 28, 2011

Law Firms

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.